$90.35−0.01 (−0.01%)
Market open · 15-min delayed · as of 9:44 AM ET
10x Genomics Inc · Corporate Actions
Splits, dividend moves, buybacks and structural changes on file for TXG, and what each one says about how management treats you, the shareholder.
•
Management posture
Returns cash, still building a record
Management returns cash through dividends and/or buybacks, but the track record is shorter or less consistent than a seasoned compounder's. Judge each action on its own coverage.
Annual raise streak
—
no dividend on fileBuyback
—
none this FY · last: $80K FY17Last split
None
no splits on fileDelist / distress
None
no red flags on fileAction history
· 1 on file · newest first✓
Reads are interpretationsEach action's read is Tenet's plain-English interpretation of the action type: a starting point, not investment advice.
Reads are Tenet's plain-English interpretation of each action type, a starting point, not investment advice.